Question Time AU

General Debate

Prostate Cancer Awareness Month

House of Representatives · Monday 1 September 2025

Official Hansard for this day (APH) · Read this debate on OpenAustralia

At a glance

Members debated a motion recognising September as Prostate Cancer Awareness Month, highlighting the disease as the most commonly diagnosed cancer in Australian men. Speakers emphasised the importance of early detection through PSA testing and acknowledged barriers faced by rural, First Nations, and high-risk men. The discussion included government investments in cancer nursing, navigation programs, and specific treatments, alongside community initiatives to reduce stigma. All speakers supported the motion, which aimed to encourage men to seek medical advice and improve health outcomes.

Outcome

The motion was agreed to without division.

Summary in reported speech - not a transcript. AI-generated, so check the official record before quoting.

How the debate unfolded

Opened the debate

Repacholi moved the motion to note that prostate cancer significantly impacts men and their communities, urging early action. Repacholi highlighted that modern screening involves simple blood tests rather than invasive procedures, aiming to reduce hesitation among men. Repacholi pointed out that rural residents, First Nations men, and those with family histories face greater barriers to care. Repacholi commended government initiatives for specialist nurses and mental health support, while recognising the role of the Prostate Cancer Foundation of Australia. Repacholi encouraged men aged 50 to 69, and younger men with risk factors, to consult their general practitioners.

Opposition response

Willcox, co-chair of the Parliamentary Friends of Prostate Cancer Awareness group, supported the motion and provided statistical context on diagnosis rates. Willcox noted that approximately 26,000 men are diagnosed annually, with survival rates improving significantly since 1982 due to better imaging and testing. Willcox highlighted disparities in screening rates between rural and metropolitan areas, calling for evidence-based guidelines to address these gaps. Willcox referenced the case of a young councillor diagnosed at 36 to underscore the need for risk-based screening discussions. Willcox recommended the motion to the House, advocating for zero deaths from prostate cancer.